Tumor response and outcome in localized high-risk soft tissue sarcomas (STS) treated with preoperative chemotherapy (CHT) with or without radiation therapy (RT) within a phase III trial from the Italian Sarcoma Group (ISG) and the Spanish Sarcoma Group (GEIS).

Authors

S. Stacchiotti

Istituto Nazionale dei Tumori, Milano, Italy

S. Stacchiotti , P. Verderio , A. Messina , C. Morosi , A. Ferraro , V. Quagliuolo , J. Martin , A. Comandone , G. Grignani , P. Picci , S. Frustaci , A. Gronchi , P. G. Casali

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Sign-In

Similar Posters

insert_chart_outlined

Poster

2016 ASCO Annual Meeting

bookmark_border

Tumor response assessment by Choi criteria in localized high-risk soft tissue sarcoma (STS) treated with chemotherapy (CT): Update at 10-year follow-up of an exploratory analysis on a phase III trial.

First Author: Silvia Stacchiotti

insert_chart_outlined

Poster

2020 ASCO Virtual Scientific Program

bookmark_border

Prognostic role of MRP1 in localized high-risk soft tissue sarcoma (STS): Translational research associated to randomized phase III trial (ISG-STS 1001).

First Author: Javier Martin Broto

insert_chart_outlined

Poster

2018 ASCO Annual Meeting

bookmark_border

Short, full-dose neoadjuvant chemotherapy in localized high-risk adult soft tissue sarcomas (STS): An exploratory subgroup analysis on responding patients in a randomized controlled trial comparing 3 neoadjuvant versus 3 neoadjuvant + 2 adjuvant cycles of full dose anthracycline and ifosfamide chemotherapy at a 10yr median FU.

First Author: Silvia Stacchiotti

insert_chart_outlined

Poster

2016 ASCO Annual Meeting

bookmark_border

Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): Long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group.

First Author: Elena Palassini